Once-daily radiotherapy fails to Improve over standard in limited-stage small-cell lung cancer

A once-daily radiotherapy regimen given concurrently with chemotherapy showed no difference in survival outcomes compared with the standard twice-daily regimen in a randomised trial of patients with limited-stage small-cell lung cancer).
Cancer Network